Amylyx Pharmaceuticals, Inc. (AMLX)

SEC filing

Amylyx Pharmaceuticals, Inc.

AMLX · CIK 1658551

4 · Aug 20, 2026 · Director, Co-Chief Executive Officer Klee Justin B. was granted 60.04K shares

Director, Co-Chief Executive Officer Klee Justin B. was granted 60.04K shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.